Nagel, Michael; Labenz, Christian; Dobbermann, Henrike et al.
Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriationEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. Bd. 34. H. 10. 2022 S. 1053-1059
Douglas, Raymond S.; Kahaly, George J.; Ugradar, Shoaib et al.
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatmentOPHTHALMOLOGY. Bd. 129. H. 4. 2022 S. 438-449
Jain, Amy Patel; Gellada, Norman; Ugradar, Shoaib et al.
Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye diseaseBRITISH JOURNAL OF OPHTHALMOLOGY. Bd. 106. H. 2. 2022 S. 165-171
Michel, Maurice; Gairing, Simon Johannes; Weinnnann-Menke, Julia et al.
The Else Kroner Research College Mainz - from chronic Inflammation to the Development of Liver Tumors and their effective TherapyGASTROENTEROLOGIE. Bd. 17. H. 4. 2022 S. 279-280
Mueller, Lukas; Gairing, Simon Johannes; Kloeckner, Roman et al.
The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapyCANCER IMAGING. Bd. 22. H. 1. 2022
Bahr, K.; Simon, P.; Schattenberg, J. et al.
THE SNORING INDEX AS AN INDICATOR FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH SLEEP APNOEA SYNDROMESLEEP MEDICINE. Bd. 100. 2022 S. S285-S285
Bahr, Katharina; Simon, Perikles; Leggewie, Barbara et al.
The Snoring Index Identifies Risk of Non-Alcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea SyndromeBIOLOGY-BASEL. Bd. 11. H. 1. 2022
Gairing, Simon Johannes; Schattenberg, Jorn M.
The unmet need of personalized HCC screening-Lessons learned from the Swedish nationwide registriesUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. Bd. 10. H. 5. 2022 S. 447-448
Triantafyllias, K.; Sauer, C.; Schwarting, A.
Therapeutic effects of complex multimodal rheumatologic treatment in the Rheumatology Center, Rhineland-PalatinateZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 81. H. 7. 2022 S. 596-604
Ridder, Dirk Andreas; Urbansky, Lana Louisa; Witzel, Hagen Roland et al.
Transforming Growth Factor-beta Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable OutcomeCANCERS. Bd. 14. H. 2. 2022